InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Saturday, 02/14/2015 3:45:46 PM

Saturday, February 14, 2015 3:45:46 PM

Post# of 403033
Interesting reading. Many posts suggest the previous research and previous trials in mice etc guarantee success for Kevetrin. Somewhere there is a good summary article that details all the various stages where once very promising drugs failed, but I cannot see taking the time to find it because I thought it to be common knowledge. Of course the drug can still fail.

Now though is an exciting time to be watching CTIX since things are picking up : setting doses and actually enrolling patients then seeing if K really helps cancer pts.

Plenty of anti physician sentiment out there, unsure why. I would assume that I am neither smarter nor dumber than all of you, and I would never suggest otherwise. At this stage in my life(57) I find that I am enamored less of smarts and more of effort, and hard work.

At some point I hope to be of some value to the board, based on seeing patients most days with celllulitis, and I will be able to tell you the buzz on Brilacidin, and whether the Infectious Disease consultant is sticking with Vancomycin and why, etc. And I would hope to see patients in the ED on K, such as the woman I saw yest with ovarian CA, widely metastatic, and struggling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News